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a b s t r a c t
Background: Skin grafting is the current gold standard for treatment of deeper burns. How patients
appraise the donor-site scar is poorly investigated. The aim of this study was to evaluate long-term
patient-reportedqualityofdonor-sitescarsaftersplitskingraftingandidentifypossiblepredictors.
Methods: A prospective cohort study was conducted. Patients were included in a Dutch burn
centre during one year. Patient-reported quality of donor-site scars and their worst burn scar
was assessed at 12 months using the Patient and Observer Scar Assessment Scale (POSAS).
Mixed model analyses were used to identify predictors of scar quality.
Results: This study included 115 donor-site scars of 72 patients with a mean TBSA burned of
11.2%. The vast majority of the donor-site scars (84.4%) were rated as having at least minor
differences with normal skin (POSAS item score 2) on one or more scar characteristics and
the overall opinion on 80.9% of the donor-site scars was that they deviated from normal skin
12 months after surgery. The overall opinion on the donor-site scar was 3.2  2.1 vs. 5.1  2.4
on the burn scar. A younger age, female gender, a darker skin type, and location on the lower
leg were predictors of reduced donor-site scar quality. In addition, time to re-epithelization
was associated with scar quality.
Conclusion: This study provided new insights in long-term scar quality of donor-sites. Donor-
site scars differed from normal skin in a large part of the population 12 months after surgery.
Results of this study can be used to inform patients on the long-term outcomes of their scars
and to tailor preventive or therapeutic treatment options.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
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1. Background
In present day burn care, excision and skin grafting is the
cornerstone in the treatment of deeper burns to facilitate
wound healing and provide a good functional and aesthetic
scar outcome [13].
On the one hand, skin grafting offers an important
therapeutic option in the treatment of burn wounds. On the
other hand, donor-sites that remain after skin grafting form
scars, which may heal aesthetically displeasing with notice-
able depigmentation and hypertrophy [46]. Scars of the
donor-sites are rectangular, linear-shaped and commonly
placed on the patients’ thigh, arms or back. Patients just have
to accept this extra scar whilst it may have an impact on their
quality of life [4,7].
The incorporation of patients’ values and opinions is
endorsed to ensure high-quality patient-centred care [810].
Although scar quality is one of the most important outcomes in
burn surgery today, there is no evidence to support therapeutic
decision-making regarding skin grafting and expected donor-
site morbidity. In massive burn injuries, donor-site scarring
might be of limited importance. However, when treating
smaller injuries, other treatment options might be considered
if significant distress for the patient is expected after surgery.
Clinical observations at our institution have shown that
caregivers seem to underestimate the impact of donor-site
scarring on patients [11]. Therefore, the main aim of this study
was to evaluate long-term patient-reported scar quality of
donor-sites one-year after surgery. Our secondary aim was to
identify factors related to patient-reported scar quality of
donor-sites in burn patients.
2. Methods
2.1. Design and participants
The present study is part of an observational prospective
cohort study. Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) guidelines were adhered to
in this study and manuscript. Patients of all ages who
underwent excision and split-skin grafting for a burn wound
between February 2017 and February 2018 in the burn centre of
the Maasstad Hospital in Rotterdam were asked to participate.
Patients were included if they were able to comply with the
study protocol and signed informed consent. A maximum of 3
donor sites per patient were included. The study was
conducted according to the principles of the Declaration of
Helsinki and Dutch laws and approved by the regional Ethics
Committee (reference number L2016119).
2.2. Treatment
Skin grafts were harvested at a depth of 0.2 mm (0.007 inch)
with an electric Aesculap1 dermatome. Adrenaline soaked
gauzes were placed on the wounds immediately after grafting
to reduce blood loss. Afterwards, donor site wounds were
covered with an alginate dressing, cotton wool and elastic
bandages, which were removed 2 weeks after surgery.
2.3. Scar quality assessment
Scar quality was assessed at 12 months after burn in the
outpatient clinic. The patient part of the Patient and Observer
Scar Assessment Scale (POSAS) version 2.0 was used to assess
the scar quality of their donor sites and of the burn scar that
they indicated as most severe. The patient scored the items
pain, itch, color, pliability, thickness, and relief. All items were
scored on a 10-point rating scale. A lower score correlates with
a better scar, where 1 resembles ‘normal skin’ and 10
resembles ‘very different from normal skin’. The mean POSAS
score was calculated by summing up the six item scores and
dividing this by 6. Furthermore, patients were asked to give
their overall opinion of the scar on a scale from 1 (best scar
imaginable) to 10 (worst scar imaginable). The outcomes of the
POSAS were divided into 3 categories: (1) low score, no
differences with normal skin: POSAS item score 1; (2)
intermediate scores, minor differences with normal skin:
POSAS item score 2 or 3; (3) high scores, major differences with
normal skin: POSAS item score  4. These cut-off points are
arbitrary in the absence of commonly used cut-off points and
in the absence of a minimal important change analysis of the
POSAS [12].
2.4. Other study parameters
Other study parameters were documented during admission,
surgery and outpatient visits. These were patient character-
istics: age at surgery, gender, skin type, diabetes yes/no and
smoking yes/no. Registered clinical characteristics were burn-
related: % total burned body surface area (TBSA), % TBSA
excised, length of stay, POSAS of the burn scar, and donor site-
related: location on the body, location in relation to the burn
wound, surface area, >2 weeks to re-epithelization, applica-
tion of pressure garment and application of silicone gel.
2.5. Statistical analysis
We compared the main baseline characteristics of participants
and nonparticipants to determine if there were any relevant
differences between the groups using the independent t-test
or Mann Whitney U tests (for continuous variables) and chi2
test (for categorical variables). Descriptive statistics were used
to assess long-term scar quality and characterize patients with
low and high POSAS scores. Pearson statistics were used to
identify the correlation between patient rated POSAS scores of
the donor-site scar and burn scar (i.e. recipient site scars).
Univariable and multivariable mixed model analyses
were performed to determine the predictive value of
patient-, clinical- and donor-site-related factors for the
mean POSAS score and mean overall opinion of the POSAS.
Mixed model analysis was used to take into account the
dependency of the multiple observations within the partic-
ipants if more than one donor site per patient was included.
Factors with univariable p < 0.20 were selected for
multivariable analyses. A backward selection procedure
was used to obtain the final models for the outcomes, in
which only variables with p < 0.10 were selected. IBM SPSS
Statistics 23 and STATA version 14 were used for the
analysis.
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3. Results
A total of 114 patients were screened for eligibility during the
study period. Of these, 106 patients were eligible to participate
and 80 patients signed informed consent. At 12 months after
surgery, 7 patients were lost to follow-up and 1 patient
deceased, resulting in a total study population of 72 patients
with 115 donor site scars. Patients included in the analysis had
a mean age of 37.4  23.0 years, 23.8% were aged 16 years, and
most were male (65.3%) (Table 1). Most burns were caused by
flames (51.4%). Mean %TBSA burned was 11.2  11.4, mean
length of hospital stay was 24.8  23.2 days, and most
participants had only 1 donor site (62.6%). Most donor-sites
were placed on the patients’ thigh (76.5%).
3.1. Donor site scar quality
The mean POSAS score (based on the six POSAS items) was
1.9  1.2 (range 1.07.2) at one-year after surgery. Eighteen
patients (25.0%) scored all six items as 1, indicating that their
donor site scar did not deviate from normal skin (all had 1
donor site scar). These patients had a mean age of 43.1  24.6
years and most (64.3%) were male. Thus, for the other donor-
site scars (n = 97, 84.3%), patients reported at least minor
differences (i.e. POSAS item score 2) on one or more scar
characteristics. Six patients (8.0%) with a total of 8 donor
sites (6.1%) reported a relatively high POSAS score (i.e.
POSAS item score 4) for all POSAS items). These patients
had a mean age of 29.7  23.9 years and most (87.5%) were
female.
The item ‘color’ was appreciated worst; for 41% of the scars,
major differences compared to normal skin were reported and
for 43% of the scars minor differences were reported (Fig. 1). For
the scar characteristics itch, pliability, thickness and relief 8
12% of the donor site scars were rated with high scores
(POSAS item score 4), while 7388% were rated with no
differences compared to normal skin (POSAS item score = 1).
The lowest ratings were for the item pain; 97% of the scars were
rated as ‘no difference to normal skin’, resulting in a mean
score of 1.1  0.6 (Fig. 1).
Patients’ mean overall opinion of their donor site scars was
3.2  2.2 (range 110) (Fig. 2). Twenty-two scars (19%, in 16
patients) were rated as 1 (i.e. ‘best scar imaginable’). These
patients had a mean age of 38.6  24.6 years and most of these
patients were male (81.3%). Thus, for all other scars (80.9%) at
least minor dissatisfaction with the scar was reported. For 40
scars, 27 patients reported a relatively poor overall opinion
(i.e. POSAS score 4). These patients had a mean age of 31.3 
21.3 years and 47.5% were male. In total, two patients rated 4
scars as 10 (i.e. ‘worst scar imaginable). These patients were
both female and had a mean age of 35.5  13.4 years. Fig. 2
shows the mean and standard deviation of the POSAS item
scores of the donor-site scar and most severe burn scar (as
indicated by the patient). The items ‘pain’ (1.1  0.7 vs 1.9 
1.8), ‘itch’ (1.6  1.7 vs 2.7  2.3), ‘color’ (3.5  2.1 vs. 5.2  2.4),
and ‘overall opinion’ (3.2  2.1 vs. 5.1  2.4) items differed
least. The items ‘pliability’ (1.9  2.0 vs. 4.2  2.6), ‘thickness’
Table 1 – Patient demographics and clinical data.
Patient characteristics No. of patients (n = 72)
Age, mean (SD, range) 37.43 (23.0, 084)








Diabetes, n(%) 6 (5.2%)






%TBSA burned, mean (SD, range) 11.2 (11.4, 0.155)
%TBSA excised, mean (SD, range) 6.2 (7.1, 0.150)
Length of stay (days), mean (SD) 24.8 (23.2)
Donor site characteristics No. of Donor sites (n =
115)
Location, n (%)
Upper back 1 (0.9%)
Upper arm 12 (10.4%)
Lower arm 1 (0.9%)
Thigh 88 (76.5%)
Lower leg 13 (11.3%)
Same limb as burn wound, n (%) 56 (48.7%)
Adjacent to burn wound, n (%) 39 (39%)
Surface (cm2), mean (SD) 167.5 (173.4)
Time to re-epithelization (>2 weeks),
n (%)
28 (24.3%)
Wound infection, n (%) 8 (7.0%)
>1 time harvested, n (%) 3 (2.6%)
Application of pressure garment, n (%) 2 (1.7%)
Application of silicone gel, n (%) 19 (17.3%)
Fig. 1 – Proportion of donor sites for which patients scored
low, intermediate, and high scores for scar-related problems
on items of the patient part of the POSAS at 12 months after
surgery. Low scores, no differences with normal skin; POSAS
item score 1; intermediate scores, minor differences with
normal skin: POSAS item score 2 or 3; high scores, major
differences with normal skin: POSAS item score 4.
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(1.7  1.7 vs. 4.4  2.8), and ‘relief’ (1.6  1.3 vs 4.8  2.6)
differed most. All items had a very low or low ICC (Pearson’s r
< 0.30).
3.2. Predictors of long-term donor-site scar quality
The results of univariable and multivariable mixed model
analysis are shown in Tables 2 and 3 respectively. In the final
model, a higher age was associated with a better donor-site
scar quality (i.e. a lower mean POSAS score (r = 0.01, SE = 0.01;
p = 0.046)). Female gender (r = 0.76, SE = 0.27; p = 0.004), a higher
Fitzpatrick skin type (r = 0.27, SE = 0.13,; p = 0.12) and time to re-
epithelization exceeding 2 weeks (r = 0.66, SE = 0.26; p = 0.016)
were associated with a poorer scar quality (i.e. higher mean
POSAS score).
For the overall opinion, a higher age was associated with a
better score (i.e. lower POSAS score (r = 0.02, SE = 0.01; p = 0.045).
Femalegender (r = 1.40, SE= 0.48; p = 0.045), location on the lower
leg (r = 0.77, SE = 0.43; p = 0.077) and time to re-epithelization
exceeding 2 weeks (r = 0.79, SE = 0.39; p = 0.044) were associated
with a poorer overall opinion on the donor-site scar. None of the
clinical characteristics were associated with patient-reported
donor-site scar quality at 12 months (Table 2).
4. Discussion
This prospective cohort study assessed patient-reported
quality of donorsite scars in a burn population one year after
surgery. The majority of the scars (84.4%) were rated as having
at least minor differences with normal skin (POSAS item score
2) on one or more scar characteristics. The overall opinion on
the majority of the donor-site scars (80.9%) was that they
deviated from normal skin.
The overall opinion of patients on their donor-site scar
differed less than 2 points (POSAS 110 point scale) and
patient-reported quality of burn scars and donor-site scars
Fig. 2 – Patient reported POSAS scores of their donor-site and
burn scar 12 months after surgery. A lower POSAS score
correlates with a better scar; a score of 10 reflects the worst
imaginable scar. *ICC < 0.3 (very low), **ICC 0.30.5 (low).
Table 2 – Univariable mixed model analysis of predictors of long-term donor-site scar quality.
Mean 6 item POSAS score Overall opinion score
Patient characteristics R coefficient SE p-value R coefficient SE p-value
Age (years) 0.01 0.01 0.114 0.02 0.01 0.158
Female gender 0.78 0.29 0.008 1.28 0.50 0.010
Fitzpatrick skin type 0.27 0.13 0.042 0.35 0.23 0.119
Diabetes 0.38 0.63 0.554 0.43 1.09 0.694
Smoking 0.58 0.31 0.061 0.83 0.53 0.117
Clinical characteristics
%TBSA burned 0.00 0.01 0.824 0.01 0.03 0.908
%TBSA excised 0.01 0.02 0.526 0.02 0.04 0.537
Total no. donor-sites 0.18 0.35 0.604 0.34 0.60 0.569
Length of stay 0.01 0.01 0.695 0.01 0.01 0.496
Donor site characteristics
Location - Body part
Trunk 0.07 0.65 0.911 0.66 1.08 0.541
Upper arm 0.37 0.37 0.320 0.07 0.63 0.914
Lower arm 0.28 0.65 0.665 1.47 1.06 0.166
Upper leg 0.08 0.21 0.689 0.23 0.35 0.519
Lower leg 0.02 0.27 0.955 0.84 0.44 0.060
Location on same limb as burn wound (yes) 0.20 0.24 0.401 0.27 0.41 0.513
Location adjacent to burn wound (yes) 0.08 0.24 0.750 0.01 0.41 0.987
Surface 0.01 0.00 0.789 0.03 0.01 0.722
Time to re-epithelization (>2 weeks) 0.64 0.24 0.008 0.75 0.41 0.066
Wound infection 0.66 0.40 0.105 0.93 0.68 0.172
>1 time harvested 0.01 0.01 0.391 0.01 0.01 0.441
Use of pressure garment 0.06 1.22 0.959 1.31 2.07 0.527
Use of silicone gel 0.74 0.38 0.054 1.04 0.67 0.118
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were not correlated, which might indicate that the individual
opinion of the patient is of more importance than biological or
genetic factors. A younger age, female gender and time to re-
epithelization were associated with reduced scar quality (both
mean POSAS item score and overall opinion on the scar). In
addition, a darker skin was associated with a poorer scar
quality (POSAS item score) and location on the lower leg was
associated with a poorer overall opinion of the patient.
A former study from our research group found that the
agreement on donor-site scar quality between patients and
caregivers is poor and that caregivers seem to underestimate
the impact of donor-site scars in  a subgroup of- patients.
Many studies have been performed on donor-site manage-
ment, ranging from different types of wound dressings to
more innovative (surgical) techniques. However, patient-
reported outcomes were hardly reported [13]. Our results
show that location on the lower leg was a predictor of
reduced patient satisfaction, which might be due to the fact
that this area is more often visible than the upper leg.
Harvesting of the skin from a different location (i.e, buttocks
or skull) may lead to a less visible donor-site and might
therefore be a relatively simple option to improve overall
satisfaction of patients. The use of other harvesting methods,
like dermal and minced skin grafting, have been described to
reduce donor-site morbidity [1316]. Also, methods that aim
to improve selective debridement (e.g. enzymatic or hydro-
surgical debridement) of burn tissue may reduce the need for
skin grafting and consequently, donor-site scarring [17,18]. If
poor patient satisfaction regarding scar quality of a donor-
site is expected, this might be an argument to support the
decision to refrain from skin grafting. Local, pedicle and free
flaps or the use of a skin stretching device for primary closure
have been described as successful in the treatment of acute
burn wounds and eliminate the need for donor-sites [1921].
Another option, although costly and time consuming, is the
use of allogenic skin substitutes or dermal regeneration
products to support the wound environment and autologous
regeneration in such way that skin grafting (and therefore
donor-site scarring) may be reduced [17,18,22]. Conversely, if
no problems regarding donors-site scar quality are expected,
early debridement and skin grafting may lead to a decrease of
the length of hospital stay [23].
Articles that report donor-site scar quality are scarce. Most
investigate difference in cosmetic outcome after the use of
different types of wound dressings and only a few used
patient-reported outcome measurement instruments [13].
Schulz et al. evaluated donor-site scar quality 2 years after
application of Biobrane or Dressilk in 11 patients and found
that patients reported all POSAS items 2 for their donor-site
scar. These lower POSAS scores might indicate that donor-site
scar quality improves after one year. On the other hand, the
patients that they included in their study were older, no
children were included and more males were included
compared to our study population. Similar to our results,
color was appreciated worst [24].
To our knowledge, only two studies investigated  the
relationship between patient- and other clinical factors and
patient-reported scar quality of donor-sites [25,26]. Karls-
son et al. reported POSAS results 8 years after surgery that
were similar to our study results, but did not find a
significant relationship between age, sex, healing time
and patient-reported scar quality. However, they invited
patients retrospectively, resulting in a study population of
only 27 patients. McBride et al. studied patient reported
donor-site scarring in children, but did not find a relation-
ship with age or sex [26]. Studies that assessed predictors of
patient-reported quality of scars after general surgical
procedures and burn injuries have, in line with our study,
reported female gender as a predictor for a worse scar
outcome [12,27,28]. Wallace et al. hypothesized that
immune and hormone responses might result in hypertro-
phic scarring in females [29]. Nevertheless, other studies on
hypertrophic scars did not find female gender as an
independent predictor [3032]. Garcia et al. state that their
clinical observations showed that female burn patients
frequently have greater difficulty choosing a donor-site
location and therefore conclude that scar outcome in
females is more important than in men [5]. This finding
is comparable with a previous study that described that
women express greater concern with their appearance than
men [33]. Moreover, many studies on health related quality
of life after burn injury report female gender as a predictor
of a reduced health related quality of life [23]. This supports
the gender differences in the patients’ opinion found in our
study and suggest that this outcome might be based on
culture rather than biological differences between males
and females. One study that used the patient scale of the
POSAS to assess the quality of burn scars also found
Table 3 – Multivariable mixed model analysis of predictors of long-term donor-site scar quality.
Mean 6 item POSAS scorea Overall opinion scoreb
Patient characteristics R coefficient SE p-value R coefficient SE p-value
Age (years) 0.01 0.01 0.046 0.02 0.01 0.045
Female gender 0.76 0.27 0.004 1.40 0.48 0.004
Fitzpatrick skin type 0.21 0.12 0.067
Donor site characteristics
Location 0.77 0.43 0.077
Lower leg
Time to re-epithelization (>2 weeks) 0.66 0.26 0.017 0.79 0.39 0.044
a Explained variance: 32.3%.
b Explained variance: 17.3%.
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differences in age categories on the items pain, color,
pliability and thickness [28]. It is important to realize that in
children under the age of 5, parents complete the patient
part of the POSAS. In literature, it has been stated that this
may lead to underestimation of the true magnitude of the
problem because pain and pruritus are difficult to assess
through the parents [30]. On the other hand, parents may be
very concerned about the appearance of the angular donor-
site scars and how they evolve if their child grows and what
they might think when they go into puberty.
An important strength of this study is that the study was
conducted in a dedicated burn centre, and thus reflects
donor-site outcome after specialized (scar) treatment.
Another asset of the study was the prospective design
which is preferred for the development of association and
prediction models [34]. Because of the strict study protocol
and study conduct there were no missing values in the
patient-, clinical and donor site characteristics. Although
patients signed informed consent, they were not aware of
the predictors that we aimed to investigate and could
therefore not influence the outcome. This study also has
some limitations. We used the POSAS to assess scar quality
and used arbitrary cut-off points in the absence of a
commonly used cut-off point or a minimal important
change analysis of the POSAS. Nevertheless, the POSAS is
the only validated scar outcome measure that takes the
opinion of the patient into account.
5. Conclusion
This study provides important new insights in long-term scar
quality of donor-sites as stated by burn patients. Even one year
after surgery the mean overall opinion of patients on donor-
site scars was remarkably high (POSAS score 3.2 (scale 110)).
Moreover, 37% of the patients reported a poor overall opinion
on the donor-site scar (i.e. POSAS score  4). Especially color of
the donor site-scars was judged to remain deviant from
normal skin. A younger age, female gender, a darker skin type,
location on the lower leg and prolonged time to re-epitheli-
zation predict patient-reported reduced donor-site scar
quality. Our study provides data that can help to better inform
patients on the long-term outcome of their injury. Further-
more, preventive and therapeutic measures can be tailored to
further improve long-term donor-site scar quality.
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